Highly focused loco-regional chemotherapy for oral cancer - IND 132234 - october 01 2017
Ended Project Grant Awarded Last action
- Award ID
- R01FD006325
- Recipient
-
Privo Technologies, Inc. UEI E6ACGUBJMQC5
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $1,246,687
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Funding
-
- $1,147,027.00 Federal
- $99,660.00 Non-federal
- Funding agency
- Office of Medical Products and Tobacco Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $99,660 | $0 | |
| Amendment | $99,660 | $99,660 | |
| Amendment | $100,000 | $0 | |
| Amendment | $398,400 | $0 | |
| Original award | $449,307 | $0 |
Quick answers
Who received award R01FD006325?
R01FD006325 was awarded to Privo Technologies, Inc. by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 1, 2019.
How much is award R01FD006325 worth?
$1,246,687 has been obligated on R01FD006325: $1,147,027 in federal funding and $99,660 in non-federal funding.
Which agency awarded R01FD006325?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded R01FD006325, with funding from Office of Medical Products and Tobacco (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award